Research Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities Tags: #CRISPRCas #Immunotherapy #TCell Engineering #Base Prime Editing #Gene Editing #Oncology #Next Gen Therapy T cells can be reprogrammed with transgenic antigen recognition receptors, including chimeric antigen receptors and T cell receptors, to selectively recognize and kill cancer cells.
